Skip Navigation LinksHome Research report list Pharma & Healthcare Pharmaceutical Global Intravenous (IV) Iron Drugs Market Report: 2013 Edition
Global Intravenous (IV) Iron Drugs Market Report: 2013 Edition
Format : Pdf (Instant Download)
Date: 29, May 2013 | Pages: 55
Electronic Access - Single User License
USD 800
Electronic Access - Corporate User License
USD 1100
Hard Copy - Mail Delivery
USD 875

With the dawn of novel technology era, companies operating in the healthcare/science/pharmaceutical/therapeutic industries are now surmounting the never touched peaks. Also the growth of these industries is overhauled by the unrelenting increase in health related issues emanating from the altering lifestyle and rapidly evolving surrounding environment. Amongst the respective industries of biological sciences, a booming industry is of IV (Intravenous) iron.


Iron is one of the most crucial elements required by the human body. It is a component of hemoglobin, the substance present in RBCs that transports oxygen throughout the body via blood. This oxygen is used by the cells for generating energy required to perform the necessary body functions. So, if the body’s iron levels fall below the accepted line, it can lead to severe health problems. Usually oral iron supplements are recommended for restoring and maintaining iron levels in the body, but oral treatment has certain limitations. For the cases where oral supplements are incapable of fulfilling the purpose, IV iron therapy is used as part of which iron is directly injected with a needle into a vein.


This report offers comprehensive analysis of the global iron products market along with the key segments viz. IV Iron and Oral Iron. Herein, the IV iron market is discussed in details. Also, the IV iron replacement therapy market of the US is covered. Furthermore, market dynamics including the key trends and developments, underlying industry growth drivers and the challenges faced by the respective market are analyzed in-depth. On the contention front, the market for IV iron is highly competitive with a handful of players dominating the whole market. The competitive landscape along with the profiles of leading industry players is also included in this report.


By combining SPSS Inc.’s data integration and analysis capabilities with our relevant findings, we have predicted the future growth of the industry. We employed various significant variables that have an impact on this industry and created regression models with SPSS Base to determine the future direction of the industry. Before deploying the regression model, the relationship between several independent or predictor variables and the dependent variable was analyzed using standard SPSS output, including charts, tables and tests.


1. Iron in Human Body: An Overview

1.1 IV Iron Application Areas
1.1.1 IV Iron Application in Nephrology
1.2 Iron Deficiency- Anemia
1.3 IV Iron Therapy for Anemia Treatment


2. Iron Medication Market Structure

2.1 Global Iron Products Market
-Market Value
-Market Segments

2.1.1 Global IV Iron Market
-Market Value

2.2 The US IV Iron Market
-Market Value
-Non-Dialysis IV Iron Market


3. Market Dynamics

3.1 Industry Trends and Developments

3.1.1 New Product Development- Soluble Ferric Pyrophosphate (SFP)
3.1.2 Bundled Payment System

3.2 Growth Drivers

3.2.1 Increasing Use of IV Iron in Gynecology
3.2.2 IV Iron Improves Quality of Treatment outside Dialysis
3.2.3 Increasing Dialysis Patient Population
3.2.4 Growing Number of Diabetic Patients Worldwide
3.2.5 Increasing Cases of Hypertension
3.2.6 Rising Healthcare Expenditure
3.2.7 Higher Spending on Medicines
3.2.8 Growing Ageing Population (+60 Years)
3.2.9 Ameliorating Economic Conditions
3.2.10 Increasing Insurance Density

3.3 Challenges

3.3.1 Stringent Regulation
3.3.2 Concerns Regarding Adverse Effects


4. Competitive Landscape

4.1 US Market
4.2 Product Contention


5. Company Profiles

5.1 Galenica Pharmaceuticals

5.1.1 Business Overview
5.1.2 Financial Overview
5.1.3 Business Strategies
-Strong Foothold in Healthcare Market
-Focus on New Product Development

5.2 Actavis Inc.

5.2.1 Business Description
5.2.2 Financial Overview
5.2.3 Business Strategies
-Strategic Acquisitions
-Intense R&D Activities

5.3 AMAG Pharmaceuticals

5.3.1 Business Oveview
5.3.2 Financial Overview
5.3.3 Business Strategies
-Focus on Research & Development
-Expanding the Existing Labels


6. Market Outlook

6.1 Market Forecast
6.2 Forecast Methodology
6.2.1 Dependent and Independent Variables
6.2.2 Correlation Analysis
6.2.3 Regression Analysis

List of Charts

Global Iron Products Market (2008-2012)
Global Iron Products Market Share (2012)
Global IV Iron Market (2006-2010)
The US IV Iron Market Size (2008-2011)
US Non-Dialysis IV Iron Market (2011 & 2012)
IV Iron – Avoidance of ESA Initiation in Pre Dialysis Patients
IV Iron – Response Rate to ESA with/without IV Iron (2004-2011)
Dialysis Patient Population Worldwide (2005-2015E)
Dialysis Patient Population Share by Region (2011)
Global Diabetes Population (2006-2011)
Causes of ESRD in the US (2011)
Worldwide Patients with End Stage Renal Disease (2005-2011)
Hypertension Prevalence in the US (2010-2015E)
Hypertension Prevalence in the Developed Europe (2010-2015E)
Global Healthcare Spending (2005-2015E)
Global Spending on Medicines (2006-2016E)
Global Spending on Medicine Share by Region (2006-2016E)
The US Spending on Medicine (2007-2016E)
Japan’s Spending on Medicine (2007-2016E)
Global Ageing Population (2005-2013F)
Global GDP (2001-2011)
World GDP per Capita (2005-2011)
Global Insurance Density (2004-2011)
Long and Short Term Concerns about IV Iron
IV Iron Market Share in the US (January 2012)
Galenica’s Revenue Share by Business Segments (2012)
Galenica’s Net Sales and Net profit (2009-2012)
Actavis’ Revenue Share by Business Segment (2012)
Actavis’ Revenues and Net Income (2009-2012)
AMAG Pharmaceuticals’ Revenues (2009-2012)
Global IV Iron Market Forecast (2010-2015E)


List of Tables

Risk Factors for CKD
SFP Clinical Trials
IV Iron Products – Safety Profile
The US Non-Dialysis IV Iron Market (2011 & 2012)
IV Iron Administration Comparison
Dependent & Independent Variables (2006-2010)
Correlation Matrix
Model Summary – Coefficient of Determination
Regression Coefficients Output

One can also purchase any particular sections from this report. Please send us an email to with your order details.
About Us    |    PRESS RELEASES    |    RESEARCH REPORTS    |    Contact Us    |    PRIVACY POLICY    |    REFUND POLICY
@ Copyright 2014 Koncept Analytics Pvt Ltd. All Rights Reserved. Web Developed By Vision IT Consultants Pvt Ltd.